durapatite has been researched along with Malignant Melanoma in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Cao, H; Cao, J; Chen, Z; Deng, J; Feng, G; Hu, K; Ran, B; Wu, H; Zhang, R; Zhang, X; Zhu, X | 1 |
Clayton, AS; McMurray, SL; Stebbins, WG; Wallace, MM | 1 |
Guo, B; Li, Z; Tang, J; Tu, C; Wang, L; Wu, H; Yang, X; Zhang, X; Zhou, Y; Zhu, X | 1 |
Chao, DL; Harbour, JW | 1 |
Guo, B; Hong, Y; Li, B; wang, Y; Zhang, L; Zhang, X | 1 |
Gupta, M; Lyon, F; Rennie, IG; Rundle, PA; Singh, AD | 1 |
Goldhirsch, A; Zava, DT | 1 |
Oestreicher, JH | 1 |
Kaltreider, SA; Newman, SA | 1 |
Ando, H; Hayashibe, K; Horikawa, T; Ichihashi, M; Kikkawa, U; Ogita, K; Oka, M; Saito, N | 1 |
Brownstein, S; Jordan, DR; Klapper, SR; Mawn, L; Punja, K | 1 |
Drobny, GP; Giachelli, CM; Gilbert, M; Long, JR; Nelson, K; Shaw, WJ; Stayton, PS | 1 |
Colen, TP; Lemij, HG; Mourits, MP; Paridaens, DA; van Den Bosch, WA | 1 |
Brugniart, C; Ducasse, A; Gotzamanis, A; Rossi, P; Segal, A | 1 |
Gupta, M; Puri, P; Rennie, IG | 1 |
Balza, E; Ponassi, M; Saginati, M; Siri, A; Zardi, L | 1 |
Dandrow, EA; Jankewicz, R; Perrella, FW | 1 |
De Potter, P; Eagle, RC; Shields, CL; Shields, JA | 1 |
1 trial(s) available for durapatite and Malignant Melanoma
Article | Year |
---|---|
Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Durapatite; Eye Enucleation; Eye Neoplasms; Eye, Artificial; Female; Humans; Male; Melanoma; Middle Aged; Orbital Implants; Saccades | 2000 |
17 other study(ies) available for durapatite and Malignant Melanoma
Article | Year |
---|---|
Nano-hydroxyapatite-evoked immune response synchronized with controllable immune adjuvant release for strengthening melanoma-specific growth inhibition.
Topics: Adjuvants, Immunologic; Durapatite; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrogels; Immunity, Cellular; Melanoma | 2022 |
Use of a Novel Biomaterial to Enhance Secondary Intention Healing.
Topics: Aged; Aged, 80 and over; Biocompatible Materials; Durapatite; Female; Gelatin; Honey; Humans; Leptospermum; Male; Melanoma; Middle Aged; Re-Epithelialization; Skin Neoplasms; Surgical Wound; Treatment Outcome | 2021 |
The in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles: influences of material factors.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Nucleus Shape; Cell Proliferation; Cell Survival; Durapatite; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2019 |
Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Durapatite; Eye Enucleation; Female; Humans; Male; Melanoma; Middle Aged; Orbit; Orbital Implants; Polyethylene; Postoperative Complications; Prosthesis Implantation; Retrospective Studies; Uveal Neoplasms; Young Adult | 2015 |
[Inhibitory Effect of Hydroxyapatite Particles with Different Size on Malignant Melanoma A375 Cells: A Preliminary Study].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Durapatite; Humans; Melanoma; Nanotubes; Particle Size | 2015 |
Bovine pericardium (Tutopatch) wrap for hydroxyapatite implants.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biocompatible Materials; Cattle; Durapatite; Eye Enucleation; Female; Humans; Male; Melanoma; Middle Aged; Orbital Implants; Pericardium; Postoperative Complications; Prospective Studies; Prosthesis Design; Treatment Outcome; Uveal Neoplasms | 2007 |
Estrogen receptor in malignant melanoma: fact or artefact?
Topics: Breast Neoplasms; Catechol Oxidase; Durapatite; Estradiol; Humans; Hydroxyapatites; In Vitro Techniques; Ligands; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidation-Reduction; Receptors, Estrogen; Tyrosine | 1983 |
Treatment of exposed coral implant after failed scleral patch graft.
Topics: Choroid Neoplasms; Conjunctiva; Durapatite; Eye Enucleation; Fasciotomy; Female; Humans; Melanoma; Middle Aged; Orbit; Prostheses and Implants; Prosthesis Failure; Sclera | 1994 |
Prevention and management of complications associated with the hydroxyapatite implant.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Choroid Neoplasms; Durapatite; Eye Enucleation; Eye Neoplasms; Eye, Artificial; Female; Humans; Infant; Male; Melanoma; Middle Aged; Postoperative Complications; Prostheses and Implants; Prosthesis Design; Prosthesis Failure; Prosthesis-Related Infections; Reoperation; Retinoblastoma; Risk Factors; Suture Techniques | 1996 |
Deletion of specific protein kinase C subspecies in human melanoma cells.
Topics: Cell Division; Chromatography; Durapatite; Humans; Immunoblotting; Isoenzymes; Melanocytes; Melanoma; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1996 |
Abscess formation within a synthetic hydroxyapatite orbital implant.
Topics: Abscess; Adult; Anti-Bacterial Agents; Choroid Neoplasms; Drug Therapy, Combination; Durapatite; Eye Enucleation; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Melanoma; Orbital Implants; Prosthesis-Related Infections; Reoperation; Staphylococcal Infections; Staphylococcus epidermidis | 1998 |
Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion.
Topics: Adsorption; Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Cell Adhesion; Circular Dichroism; Durapatite; Humans; Magnetic Resonance Spectroscopy; Melanoma; Models, Molecular; Molecular Sequence Data; Oligopeptides; Osteopontin; Peptide Fragments; Protein Binding; Protein Structure, Secondary; Receptors, Vitronectin; Recombinant Fusion Proteins; Salivary Proteins and Peptides; Sialoglycoproteins; Tumor Cells, Cultured | 2000 |
[Tolerance of orbital implants. Retrospective study on 14 years].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biocompatible Materials; Carcinoma, Squamous Cell; Choroid Neoplasms; Durapatite; Eye Enucleation; Eye Injuries; Eye, Artificial; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Orbital Implants; Orbital Neoplasms; Retrospective Studies; Silicones; Time Factors | 2001 |
Use of bovine pericardium as a wrapping material for hydroxyapatite orbital implants.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biocompatible Materials; Cattle; Choroid Neoplasms; Durapatite; Eye Enucleation; Female; Humans; Intraoperative Complications; Male; Melanoma; Middle Aged; Orbital Implants; Pericardium; Prosthesis Implantation; Retrospective Studies | 2002 |
A simple procedure for tenascin purification.
Topics: Cell Adhesion Molecules, Neuronal; Cell Line; Chondroitin Sulfates; Chromatography; Chromatography, Affinity; Culture Media; Durapatite; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Humans; Hydroxyapatites; Macromolecular Substances; Melanoma; Molecular Weight; Neoplasm Proteins; Tenascin | 1992 |
Phospholipase C from human melanoma: purification and characterization of a phosphatidylinositol-selective enzyme.
Topics: Animals; Cell Line; Chromatography; Chromatography, Affinity; Chromatography, Ion Exchange; Durapatite; Electrophoresis, Polyacrylamide Gel; Humans; Hydroxyapatites; Kinetics; Melanoma; Mice; Mice, Nude; Molecular Weight; Neoplasm Transplantation; Phosphatidylinositols; Substrate Specificity; Transplantation, Heterologous; Type C Phospholipases | 1991 |
Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.
Topics: Aged; Choroid Neoplasms; Connective Tissue; Cranial Nerve Neoplasms; Durapatite; Eye Enucleation; Humans; Hydroxyapatites; Male; Melanoma; Optic Nerve; Orbit; Prostheses and Implants; Tomography, X-Ray Computed | 1991 |